Part of the planned global expansion of DSM
DSM Pharmaceutical Products (DPP) is to sell eight active pharmaceutical ingredients (APIs) manufactured by Indian firm Indoco Remedies of Mumbai, India, in a new agreement that is a step forward in DSM’s planned global expansion.
The APIs are used in the production of pharmaceutical finished dosages.
‘This is a step in our announced strategy to accelerate growth via partnerships and expansion in Asia to build a product portfolio alongside our custom manufacturing operations, supplying access to high demand treatments,’ said Alexander Wessels, president and chief executive of DSM Pharmaceutical Products.
‘It allows DPP to build a competence base in India.’
Indoco Remedies’ chairman and md Suresh Kare added: “Today in the era of alliances and partnerships, organisations are coming together to penetrate and capture a larger share of the potential opportunities in the market place. Indoco is active in forging such alliances and this one with DSM is a step in that direction.’